120 related articles for article (PubMed ID: 7475855)
1. Low-dose versus high-frequency regimens in Gaucher's disease.
Maródi L
Lancet; 1995 Nov; 346(8987):1434. PubMed ID: 7475855
[No Abstract] [Full Text] [Related]
2. Low-dose versus high-frequency regimens in Gaucher's disease.
Hollak CE; Goudsmit R; van Oers MH
Lancet; 1996 Feb; 347(8998):406-7. PubMed ID: 8598739
[No Abstract] [Full Text] [Related]
3. Economic malpractice in the treatment of Gaucher's disease.
Beutler E
Am J Med; 1994 Jul; 97(1):1-2. PubMed ID: 8030649
[No Abstract] [Full Text] [Related]
4. IV epoprostenol in Gaucher's disease.
Elstein D; Zimran A
Chest; 2000 Jun; 117(6):1821. PubMed ID: 10858430
[No Abstract] [Full Text] [Related]
5. Treatment regimens in Gaucher's disease.
Beutler E
Lancet; 1995 Aug; 346(8974):581-2. PubMed ID: 7658807
[No Abstract] [Full Text] [Related]
6. A less costly regimen of alglucerase to treat Gaucher's disease.
Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E
N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900
[TBL] [Abstract][Full Text] [Related]
7. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
Hollak CE; Aerts JM; Goudsmit R; Phoa SS; Ek M; van Weely S; von dem Borne AE; van Oers MH
Lancet; 1995 Jun; 345(8963):1474-8. PubMed ID: 7769902
[TBL] [Abstract][Full Text] [Related]
8. [Financing of enzyme treatment in Gaucher disease].
Wisløff F
Tidsskr Nor Laegeforen; 2003 Feb; 123(3):364. PubMed ID: 12640908
[No Abstract] [Full Text] [Related]
9. Replacement therapy with imiglucerase for type 1 Gaucher's disease.
Zimran A; Elstein D; Levy-Lahad E; Zevin S; Hadas-Halpern I; Bar-Ziv Y; Foldes J; Schwartz AJ; Abrahamov A
Lancet; 1995 Jun; 345(8963):1479-80. PubMed ID: 7769903
[TBL] [Abstract][Full Text] [Related]
10. [Cost reduction in the treatment of Gaucher s disease].
García Salom P; Acedo A
Farm Hosp; 2007; 31(3):194-5. PubMed ID: 17941761
[No Abstract] [Full Text] [Related]
11. Enzyme replacement therapy in type 1 and type 3 Gaucher's disease.
Zimran A; Elstein D; Abrahamov A
Lancet; 1995 Feb; 345(8947):451-2. PubMed ID: 7853968
[No Abstract] [Full Text] [Related]
12. Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.
Beck M; Valadares ER; Lotz J
Clin Investig; 1993 Jan; 71(1):78. PubMed ID: 8453266
[No Abstract] [Full Text] [Related]
13. Treatment of Gaucher's disease.
Moscicki RA; Taunton-Rigby A
N Engl J Med; 1993 May; 328(21):1564; author reply 1567-8. PubMed ID: 8373459
[No Abstract] [Full Text] [Related]
14. Treatment of Gaucher's disease.
Barton NW; Brady RO; Dambrosia JM
N Engl J Med; 1993 May; 328(21):1564-5; author reply 1567-8. PubMed ID: 8479496
[No Abstract] [Full Text] [Related]
15. No price too high?
Garber AM
N Engl J Med; 1992 Dec; 327(23):1676-8. PubMed ID: 1435903
[No Abstract] [Full Text] [Related]
16. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
Whittington R; Goa KL
Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294
[TBL] [Abstract][Full Text] [Related]
17. Imiglucerase and its use for the treatment of Gaucher's disease.
Weinreb NJ
Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336
[TBL] [Abstract][Full Text] [Related]
18. [Enzyme therapy of Gaucher's disease].
Beck M
Dtsch Med Wochenschr; 1993 Jun; 118(25):964-5. PubMed ID: 8519225
[No Abstract] [Full Text] [Related]
19. Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
Clarke JT; Amato D; Deber RB
CMAJ; 2001 Sep; 165(5):595-6. PubMed ID: 11563212
[No Abstract] [Full Text] [Related]
20. [Diagnosis and therapy of Gaucher disease].
Ehlen C; Heintges T; Niederau C
Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
